Physician

Santhosh Ambika, MD

According to 2025 Medicare claims, Santhosh Ambika, MD (NPI: 1174747323) practices hematology/oncology in the Reno, NV market, with the plurality of this provider's patient population coming from Washoe, NV. This provider's primary affiliated billing organization is JOHN A SHIELDS MD AND STEVEN A SCHIFF MD A PROFESSIONAL CORPORATION (NPI: 1861514580; TIN: 880152239) and primary practice location at 89511-2250. Ambika is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Ambika's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 770 traditional Medicare patients, billed 222,211 HCPCS/CPT codes, and received $5,120,104 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,354 prescription claims across 280 beneficiaries totaling $6,376,029 in drug costs, led by Revlimid (Lenalidomide). DME data shows 68 claims. Open Payments data shows 85 records totaling $22,511. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $70,304 to $5,120,104. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $900,003 to $6,376,029. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.1M2015 Medicare payment: $70,304 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $195,252 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $196,609 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $132,501 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $882,616 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,345,031 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,608,176 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,024,262 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,990,688 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,120,104 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154621,361$70,304
201642610,035$195,252
20174354,708$196,609
20186041,841$132,501
201971439,427$882,616
202067094,276$2,345,031
2021748124,001$2,608,176
202267795,725$2,024,262
2023740164,035$3,990,688
2024770222,211$5,120,104

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.2M$6.4M2015 Drug cost: $900,003 (USD; Tot_Drug_Cst)2016 Drug cost: $883,272 (USD; Tot_Drug_Cst)2017 Drug cost: $1,628,962 (USD; Tot_Drug_Cst)2018 Drug cost: $3,408,113 (USD; Tot_Drug_Cst)2019 Drug cost: $3,406,682 (USD; Tot_Drug_Cst)2020 Drug cost: $3,531,908 (USD; Tot_Drug_Cst)2021 Drug cost: $3,395,039 (USD; Tot_Drug_Cst)2022 Drug cost: $4,205,458 (USD; Tot_Drug_Cst)2023 Drug cost: $5,461,124 (USD; Tot_Drug_Cst)2024 Drug cost: $6,376,029 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015181868$900,003
2016157634$883,272
2017167735$1,628,962
2018226939$3,408,113
2019210784$3,406,682
2020189892$3,531,908
20212131,042$3,395,039
20222321,034$4,205,458
20232331,242$5,461,124
20242801,354$6,376,029

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$15K$30K2015 Medicare payment: $30,344 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $18,709 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $20,381 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $15,262 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $10,722 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $6,786 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $6,915 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,872 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $28,704 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,536 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R70$30,344
2016N/R43$18,709
2017N/R49$20,381
2018N/R94$15,262
201926113$10,722
20202474$6,786
20212594$6,915
2022N/R85$2,872
2023N/R102$28,704
2024N/R68$1,536

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more240550$137
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4571,116$94
80053Blood test, comprehensive group of blood chemicals245544$10
36415Insertion of needle into vein for collection of blood sample3931,015$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3911,104$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide581,409$806,050
JakafiRuxolitinib Phosphate501,484$765,763
BrukinsaZanubrutinib611,830$746,678
LenalidomideLenalidomide34791$365,633
PomalystPomalidomide21581$351,610

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R22$795
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R20$345
J8999Prescription drug, oral, chemotherapeutic, nosNN/R11$207
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R15$188

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.85$22,511ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Santhosh Ambika, MD?

Tedicare shows public-source Medicare data for Santhosh Ambika, MD (NPI 1174747323), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Santhosh Ambika, MD have ACO affiliation data?

Santhosh Ambika, MD is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Santhosh Ambika, MD?

Santhosh Ambika, MD is linked to JOHN A SHIELDS MD AND STEVEN A SCHIFF MD A PROFESSIONAL CORPORATION (billing NPI 1861514580) in the available physician profile data.

Does Santhosh Ambika, MD have Open Payments data?

Santhosh Ambika, MD has 85 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.